Industry News (Joint Venture)

Agreement Signed To Distribute RIGScan Cancer Products

Published in Cancer Weekly, October 16th, 1995

Neoprobe Corp., Dublin, Ohio, signs agreement with Syncor International Corp. for distribution of Neoprobe's RIGScan radiopharmaceutical products for surgical detection and treatment of cancer.

Syncor will be responsible for distributing the products throughout North America and other countries where Syncor has radiopharmacies.

Gene McGrevin, Syncor president and CEO, said, "We believe our alliance with Neoprobe is a good corporate fit. The company's cancer targeting agents will be distributed to hospitals with radiopharmacies, and that is our area of expertise. We look forward to working with Neoprobe from product launch through building sales, as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-10-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry